Search
clascoterone (Cassiopea, Breezula, Winlevi)
Indications:
- moderate to severe acne
- androgenic alopecia
Dosage:
1% cream (Winlevi) for acne
7.5%-(Breezula) for androgenic alopecia
General
androgen receptor antagonist; androgen receptor signaling inhibitor (ARSI)
topical agent
Database Correlations
PUBCHEM cid=11750009
References
- Lyles A
MedPage Today. March 06, 2019
https://www.medpagetoday.com/meetingcoverage/aad/78410
- Hebert A.
Clascoterone topical cream, 1%: a novel, topical, local, selective,
androgen receptor antagonist: results from two phase 3 studies
treating children and adult patients with facial acne vulgaris.
American Academy of Dermatology (AAD) 2019